Sex-specific vulnerabilities in cannabis-induced psychosis: A scoping review.
Valerio Ricci, Domenico de Berardis, Giovanni Martinotti, Giuseppe Maina
Asian Journal of Psychiatry July 8, 2026 DOI: 10.1016/j.ajp.2026.105086 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key findings | The review identifies sex-based paradoxes in cannabis-induced psychosis: females may lose their typical advantage in age of onset, and there are sex-specific genetic vulnerabilities (e.g., BDNF polymorphisms), differential neurobiological responses, and age-dependent vulnerability patterns. These findings challenge traditional risk models and support sex-specific clinical approaches. |
Abstract
Background: Cannabis-induced psychosis presents complex sex-based disparities that challenge traditional epidemiological patterns. While males demonstrate higher cannabis use rates, emerging evidence reveals paradoxical vulnerability patterns where females may show heightened susceptibility to cannabis-related psychotic outcomes despite lower consumption rates.
Objective: To map evidence for sex-specific vulnerability windows in cannabis-induced psychosis, examining neurobiological mechanisms, genetic factors, and developmental periods contributing to gender disparities.
Methods: We conducted a systematic search of major databases for studies published between 2000 and 2024 examining gender differences in cannabis-induced psychosis, regardless of whether such differences were a primary or secondary objective. Two independent reviewers screened articles and extracted data using standardized forms following scoping review methodology. Study characteristics, including methodological rigor, were charted using the Newcastle-Ottawa Scale as a descriptive indicator rather than a basis for weighted synthesis.
Results: From 2847 initial records, 30 studies met inclusion criteria and were analyzed. The review identified several sex-based paradoxes in cannabis-induced psychosis: (1) elimination of typical female advantage in age of psychosis onset; (2) sex-specific genetic vulnerabilities, particularly Brain Derived Neurotrophic Factor (BDNF) polymorphisms; (3) differential neurobiological responses to cannabis exposure; (4) age-dependent vulnerability patterns varying by gender. These findings challenge traditional risk models and reveal complex interactions between biological sex, developmental timing, and cannabis exposure.
Conclusions: Sex-specific vulnerabilities in cannabis-induced psychosis reflect complex interactions between hormonal factors, genetic polymorphisms, and developmental timing. These findings necessitate sex-specific approaches to prevention, assessment, and treatment.
Comparable studies
Other systematic reviews and meta-analyses on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Effects of cannabis use on outcomes of psychotic disorders: systematic review People with psychotic disorders, as examined in 13 longitudinal studies | 2008 | Systematic review | |
| The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample Patients with established schizophrenia (meta-analysis: 572) and patients with... | 2010 | Meta-analysis and cross-sectional observational study | n = 700 |
| Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review | 2020 | Systematic review | |
| Neuroimaging in cannabis use: a systematic review of the literature Cannabis users and controls in neuroimaging studies | 2009 | Systematic review | |
| Human Laboratory Studies on Cannabinoids and Psychosis. Healthy human subjects and individuals with schizophrenia | 2016 | Systematic review |
Citations in the library
Cites 16
- Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis World Psychiatry September 22, 2016
- Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review Brain Sciences March 15, 2022
- The Cannabis-Psychosis Spectrum: Clinical Manifestations, Conversion Risk, and Therapeutic Strategies Clinical Neuropsychopharmacology and Addiction August 6, 2025
- Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study American Journal on Addictions September 1, 2025
- First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness. Psychiatry Research 2023
and 11 more in the library